Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder|
|Citation:||Human Molecular Genetics, 2009; 18(8):1504-1509|
|Publisher:||Oxford Univ Press|
|Sarah Cohen-Woods, Daria Gaysina, Nick Craddock, Anne Farmer, Joanna Gray, Cerisse Gunasinghe, Farzana Hoda, Lisa Jones, Jo Knight, Ania Korszun, Michael J. Owen, Abram Sterne, Ian W. Craig and Peter McGuffin|
|Abstract:||It has been suggested that alteration in the muscarinic-cholinergic system is involved in modulation of mood. Three studies have reported linkage on chromosome 7 with major depressive disorder (MDD) in or close to a region containing the muscarinic receptor CHRM2 gene. A haplotype of SNPs located in CHRM2 (rs1824024–rs2061174–rs324650) has been significantly associated with MDD in a previous study. We report the first study investigating this gene in a large, adequately powered, clinical depression case–control sample (n = 1420 cases, 1624 controls). Our data fail to support association with the CHRM2 polymorphisms previously implicated in the genetic aetiology of depression. It is possible our failure to replicate may be a consequence of differences in definition of the MDD phenotype and/or ethnic differences.|
|Keywords:||Humans; Recurrence; Receptor, Muscarinic M2; Case-Control Studies; Depressive Disorder; Haplotypes; Middle Aged; Female; Male|
|Rights:||© The Author 2009|
|Appears in Collections:||Psychiatry publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.